1. Home
  2. IQV vs AME Comparison

IQV vs AME Comparison

Compare IQV & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • AME
  • Stock Information
  • Founded
  • IQV 1982
  • AME 1930
  • Country
  • IQV United States
  • AME United States
  • Employees
  • IQV N/A
  • AME N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • AME Industrial Machinery/Components
  • Sector
  • IQV Health Care
  • AME Industrials
  • Exchange
  • IQV Nasdaq
  • AME Nasdaq
  • Market Cap
  • IQV 36.4B
  • AME 43.2B
  • IPO Year
  • IQV 2013
  • AME N/A
  • Fundamental
  • Price
  • IQV $208.58
  • AME $196.38
  • Analyst Decision
  • IQV Buy
  • AME Buy
  • Analyst Count
  • IQV 18
  • AME 10
  • Target Price
  • IQV $237.89
  • AME $213.00
  • AVG Volume (30 Days)
  • IQV 1.8M
  • AME 1.3M
  • Earning Date
  • IQV 10-28-2025
  • AME 10-30-2025
  • Dividend Yield
  • IQV N/A
  • AME 0.63%
  • EPS Growth
  • IQV N/A
  • AME 10.46
  • EPS
  • IQV 7.30
  • AME 6.34
  • Revenue
  • IQV $15,904,000,000.00
  • AME $7,164,270,000.00
  • Revenue This Year
  • IQV $6.14
  • AME $6.18
  • Revenue Next Year
  • IQV $5.28
  • AME $7.53
  • P/E Ratio
  • IQV $28.87
  • AME $31.11
  • Revenue Growth
  • IQV 3.85
  • AME 3.67
  • 52 Week Low
  • IQV $134.65
  • AME $145.02
  • 52 Week High
  • IQV $225.91
  • AME $204.15
  • Technical
  • Relative Strength Index (RSI)
  • IQV 49.84
  • AME 59.96
  • Support Level
  • IQV $207.01
  • AME $196.40
  • Resistance Level
  • IQV $212.68
  • AME $199.81
  • Average True Range (ATR)
  • IQV 5.82
  • AME 3.97
  • MACD
  • IQV -1.71
  • AME 0.95
  • Stochastic Oscillator
  • IQV 10.15
  • AME 63.49

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About AME AMETEK Inc.

Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.

Share on Social Networks: